Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.7)
Index Copernicus  – 161.11; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2015, vol. 24, nr 3, May-June, p. 379–383

doi: 10.17219/acem/22287

Publication type: editorial

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Obesity Paradox in the Course of Cerebrovascular Diseases

Anna Brzecka1,A,B,C,D,E,F, Maria Ejma2,B,C,D,E

1 Department of Pulmonology and Lung Cancer, Wroclaw Medical University, Poland

2 Department of Neurology, Wroclaw Medical University, Poland


Obesity remains an important risk factor of cardiovascular and cerebrovascular diseases. However, it has been observed that increased body fat and body mass index predicted longer survival after the occurrence of a cardiovascular event. This observation has been named the obesity paradox. Initially, the term obesity paradox referred to the observation of the better outcome of cardiovascular diseases, such as heart failure and coronary heart disease, in obese patients as compared to underweight and normal-weight patients. Recently, similar, although fewer, observations confirm the occurrence of the obesity paradox in patients with acute cerebrovascular diseases. The underlying reasons for the protective effects of excessive body fat tissue against the consequences of acute cardiovascular and cerebrovascular diseases are poorly understood. The effect of preconditioning may be associated with the obesity paradox. The issue of the correlation between obesity and better survival of patients with cardiovascular and cerebrovascular diseases still remains largely unexplored. Debates for and against the obesity paradox continue.

Key words

obesity, obesity paradox, cerebrovascular diseases, cardiovascular diseases, preconditioning.

References (40)

  1. Ritchie SA, Connell JM: The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 2007, 17, 319–326.
  2. Lavie CJ, Milani RV, Ventura HO: Obesity and cardiovascular disease: risk factor, paradox and impact of weight loss. J Am Coll Cardiol 2009, 53, 1925–1932.
  3. Lavie CJ, Osman AF, Milani RV, Mehra MR: Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 2003, 91, 891–894.
  4. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC: Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004, 43, 1439–1444.
  5. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA: Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008, 156, 13–22.
  6. Doehner W, Erdmann E, Cairns R, Clark AL, Dormandy JA, Ferrannini E, Anker SD: Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular comorbidity: An analysis of the PROactive study population. Int J Cardiol 2012, 162, 20–26.
  7. Hamer M, Stamatakis E: Overweight and obese cardiac patients have better prognosis despite reporting worse perceived health and more conventional risk factors. Prev Med 2013, 57, 12–16.
  8. Ballo P, Betti I, Barchielli A, Castelli G, Luca LD, Gheorghiade M, Zuppiroli A: Body mass index, gender, and clinical outcome among hypertensive and diabetic patients with stage A/B heart failure. Obesity (Silver Spring) 2013, 20. doi:10.1002/oby.20420. [Epub ahead of print]
  9. Clark AL, Fonarow GC, Horwich TB: Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Card Fail 2011, 17 374–380.
  10. Nagarajan V, Cauthen CA, Starling RC, Tang WH: Prognosis of morbid obesity patients with advanced heart failure. Congest Heart Fail 2013, 19, 160–164.
  11. Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, Pepine CJ: Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 2007, 120, 863–870.
  12. Ryu WS, Lee SH, Kim CK, Kim BJ, Yoon BW: Body mass index, initial neurological severity and long-term mortality in ischemic stroke. Cerebrovasc Dis 2011, 32, 170–176.
  13. Le-Bert G, Santana O, Pineda AM, Zamora C, Lamas GA, Lamelas J: The obesity paradox in elderly obese patients undergoing coronary artery bypass surgery. Interact Cardiovasc Thorac Surg 2011, 13, 124–127.
  14. Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T: Obesity paradox in Japanese patients after percutaneous coronary intervention: An observation cohort study. J Cardiol 2013, 62, 18–24.
  15. Kim BJ, Lee SH, Jung KH, Yu KH, Lee BC, Roh JK: For Korean Stroke Registry investigators: Dynamics of obesity paradox after stroke, related to time from onset, age, and causes of death. Neurology 2012, 79, 856–863.
  16. Vemmos K, Ntaios G, Spengos K, Savvari P, Vemmou A, Pappa T, Manios E, Georgiopoulos G, Alevizaki M: Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox. Stroke 2011, 42, 30–36.
  17. Chiquete E, Cantú-Brito C, Villarreal-Careaga J, Murillo-Bonilla LM, Rangel-Guerra R, León-Jiménez C, Ochoa-Guzmán A, Ramos-Moreno A, Arauz A, Barinagarrementeria F, Panduro A, Ruiz-Sandoval JL: Obesity paradox and functional recovery in first-ever acute ischemic stroke survivors: the PREMIER study. Rev Neurol 2010, 51, 705–713.
  18. Ovbiagele B, Bath PM, Cotton D, Vinisko R, Diener HC: Obesity and recurrent vascular risk after a recent ischemic stroke. Stroke 2011, 42, 3397–3402.
  19. Andersen KK, Olsen TS: Body Mass Index and Stroke: Overweight and Obesity Less Often Associated with Stroke Recurrence. J Stroke Cerebrovasc Dis 2013, 22, 576-581. doi:pii: S1052-3057(13)00260-7. 10.1016 j.jstrokecerebrovasdis. 2013.06.031. [Epub ahead of print]
  20. Kim BJ, Lee SH, Ryu WS, Kim CK, Lee J, Yoon BW: Paradoxical longevity in obese patients with intracerebral hemorrhage. Neurology 2011, 76, 567–573.
  21. Hong NS, Kim KS, Lee IK, Lind PM, Lind L, Jacobs DR, Lee DH: The association between obesity and mortality in the elderly differs by serum concentrations of persistent organic pollutants: a possible explanation for the obesity paradox. Int J Obes (Lond) 2012, 36, 1170–1175.
  22. Lavie CJ, Cahalin LP, Chase P, Myers J, Bensimhon D, Peberdy MA, Ashley E, West E, Forman DE, Guazzi M, Arena R: Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc 2013, 88, 251–258.
  23. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74, 1124–1136.
  24. Dorner TE, Rieder A: Obesity paradox in elderly patients with cardiovascular diseases. Int J Cardiol 2012, 155, 56–65.
  25. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR: Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 2000, 48, 285–296.
  26. Kirino T: Ischemic tolerance. J Cereb Blood Flow Metab 2002, 22, 1283–1296.
  27. Dirnagl U, Simon RP, Hallenbeck JM: Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003, 26, 248–254.
  28. Ozeke O, Ozer C, Gungor M, Celenk MK, Dincer H, Ilicin G: Chronic intermittent hypoxia caused by obstructive sleep apnea may play an important role in explaining the morbidity-mortality paradox of obesity. Med Hypotheses 2011, 76, 61–63.
  29. Lavie L: Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea. Front Biosci (Elite Ed) 2012, 4, 1391–1403.
  30. Levy P, Tamisier R, Arnaud C, Monneret D, Baguet JP, Stanke-Labesque F, Dematteis M, Godin-Ribuot D, Ribuot C, Pepin JL: Sleep deprivation, sleep apnea and cardiovascular diseases. Front Biosci (Elite Ed) 2012, 4, 2007–2021.
  31. Lavie L, Lavie P: Ischemic preconditioning as a possible explanation for the age decline relative mortality in sleep apnea. Med Hypotheses 2006, 66, 1069–1073.
  32. Steiner S, Schueller PO, Schulze V, Strauer BE: Occurrence of coronary collateral vessels in patients with sleep apnea and total coronary occlusion. Chest 2010, 137, 516–520.
  33. Brzecka A: Brain preconditioning and obstructive sleep apnea syndrome. Acta Neurobiol Exp (Wars) 2005, 65, 213–220.
  34. Cepeda-Valery B, Pressman GS, Figueredo VM, Romero-Corral A: Impact of obesity on total and cardiovascular mortality-fat or fiction? Nat Rev Cardiol 2011, 8, 233–237.
  35. Dallongeville J, Bhatt DL, Steg PG, Ravaud P, Wilson PW, Eagle KA, Goto S, Mas JL, Montalescot G: Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH Registry. Eur J Prev Cardiol 2011, 19, 241–249.
  36. Akin I, Tölg R, Hochadel M, Bergmann MW, Khattab AA, Schneider S, Senges J, Kuck KH, Richardt G, Nienaber CA: DES.DE (German Drug-Eluting Stent) Study Group: No evidence of “obesity paradox” after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter german des. de (german drug-eluting stent) registry. JACC Cardiovasc Interv 2012, 5, 162–169.
  37. Zamora E, Lupón J, de Antonio M, Urrutia A, Coll R, Díez C, Altimir S, Bayés-Genís A: The obesity paradox in heart failure: Is etiology a key factor? Int J Cardiol 2013, 166, 601–605.
  38. Azimi A, Charlot MG, Torp-Pedersen C, Gislason GH, Køber L, Jensen LO,Thayssen P, Ravkilde J, Tilsted HH, Lassen JF, Thuesen L: Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease. Heart 2013, 99, 655–660.
  39. Shehab A, Al-Dabbagh B, Alhabib K, Alsheikh-Ali A, Almahmeed W, Sulaiman K, Al-Motarreb A, Suwaidi JA, Hersi A, Alfaleh H, Asaad N, Alsaif S, Amin H, Alanbaei M, Nagelkerke N, Abdulle A: The Obesity Paradox in Patients With Acute Coronary Syndrome: Results From the Gulf RACE-2 Study. Angiology 2014, 65, 585-589.
  40. Zhao L, Du W, Zhao X, Liu L, Wang C, Wang Y, Wang A, Liu G, Wang Y, Xu Y: Favorable Functional Recovery in Overweight Ischemic Stroke Survivors: Findings from the China National Stroke Registry. J Stroke Cerebrovasc Dis 2013, 12. pii: S1052-3057(13)00409-6. doi: 10.1016/j.jstrokecerebrovasdis. 2013.10.002.